(19)
(11)EP 2 710 013 A1

(12)

(43)Date of publication:
26.03.2014 Bulletin 2014/13

(21)Application number: 12789931.8

(22)Date of filing:  18.05.2012
(51)International Patent Classification (IPC): 
C07D 498/04(2006.01)
(86)International application number:
PCT/US2012/038523
(87)International publication number:
WO 2012/162129 (29.11.2012 Gazette  2012/48)
(84)Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30)Priority: 20.05.2011 IN DE14522011
01.07.2011 US 201161503728 P

(71)Applicant: Glaxosmithkline Intellectual Property (No. 2) Limited
Brentford, Middlesex TW8 9GS (GB)

(72)Inventors:
  • QIN, Donghui
    Collegeville, PA 19426 (US)
  • CHEUNG, Mui
    King of Prussia, PA 19406 (US)
  • JOSHI, Hemant
    Navi-mumbai (IN)
  • TANGIRALA, Raghuram
    Navi-Mumbai (IN)
  • BETHI, Sridhar, Reddy
    Navi-Mumbai (IN)

(74)Representative: Drury, Elizabeth Anne 
GlaxoSmithKline Global Patents CN925.1 980 Great West Road
Brentford, Middlesex TW8 9GS
Brentford, Middlesex TW8 9GS (GB)

  


(54)NOVEL COMPOUNDS AS DIACYLGLYCEROL ACYLTRANSFERASE INHIBITORS